Japan Housing Finance Agency's Three Collateralized Bond Issuances Rated 'AA' Aug 08

  • ID: 2049262
  • August 2008
  • Region: Japan
  • Standard & Poors
1 of 3

SINGAPORE (Standard & Poor's) Aug. 27, 2008--Standard & Poor's Ratings Services today assigned its 'AA' senior unsecured local currency long-term debt rating to Japan Housing Finance Agency's (JHF; AA/Stable/--) collateralized bonds that were issued today. The 'AA' rating was assigned to the following bonds: (1) -4.7 billion, 1.17% 16th nonguaranteed bonds due Sept. 20, 2013; (2) -10 billion, 2.15% 18th nonguaranteed bonds due Sept. 20, 2023; and (3) -16.9 billion, 2.34% 19th nonguaranteed bonds due June 20, 2028. JHF is the only government-supported entity (GSE) in Japan that specializes in supporting the activities of the housing-loan market, and was established on April 1, 2007, to succeed the operations of Government Housing Loan Corp. (GHLC), which was abolished on March 31,...

Companies mentioned in this report are: Japan Housing Finance Agency
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Japan Housing Finance Agency

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.